Citadel Advisors - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 22 filers reported holding MOLECULIN BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q1 2020$22,000
+15.8%
36,003
+71.1%
0.00%
Q4 2019$19,000
-13.6%
21,047
-1.9%
0.00%
Q4 2018$22,000
+22.2%
21,461
+93.4%
0.00%
Q3 2018$18,000
-10.0%
11,095
-35.9%
0.00%
Q1 2017$20,00017,3040.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2020
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 101,781$81,0000.01%
Levy Wealth Management Group, LLC 14,036$11,0000.01%
WOODMONT INVESTMENT COUNSEL LLC 12,000$10,0000.00%
Renaissance Technologies 948,503$756,0000.00%
Qube Research & Technologies Ltd 132,238$105,0000.00%
Core Wealth Advisors, Inc. 1,711$1,0000.00%
UBS Group AG 36,726$29,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 12,342$10,0000.00%
TRUE Private Wealth Advisors 2,500$1,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders